InVentiv focuses on product launches; Merck, Novo join TransCelerate;

> InVentiv Health's Campbell Alliance consulting business is offering a new service devoted to product launches. More

> Merck ($MRK) and Novo Nordisk ($NVO) have joined TransCelerate BioPharma, a group of major drugmakers united to improve how the industry conducts R&D. News

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.